ABEO vs OKTA · rev $20.1M vs P/E 84, rev $1.57B
Abeona Therapeutics Inc (ABEO) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
ABEO currently screens at market cap $301.8M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the ABEO and OKTA stock pages for the full models.
Not investment advice.